Twelve-Week Rifapentine Plus Isoniazid Versus 9-Month Isoniazid for the Treatment of Latent Tuberculosis in Renal Transplant Candidates

Title
Twelve-Week Rifapentine Plus Isoniazid Versus 9-Month Isoniazid for the Treatment of Latent Tuberculosis in Renal Transplant Candidates
Authors
Keywords
-
Journal
TRANSPLANTATION
Volume 101, Issue 6, Pages 1468-1472
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2016-07-14
DOI
10.1097/tp.0000000000001329

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started